A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide
Condition(s):H. Pylori InfectionLast Updated:April 29, 2014Withdrawn
Hide Studies Not Open or Pending
Condition(s):H. Pylori InfectionLast Updated:April 29, 2014Withdrawn
Condition(s):SinusitisLast Updated:March 14, 2012Completed
Condition(s):Ceftolozane/Tazobactam; Imipenem/Relebactam; Hematology and OncologyLast Updated:December 12, 2019Unknown status
Condition(s):Intra Abdominal InfectionsLast Updated:December 1, 2020Completed
Condition(s):Surgical Site InfectionLast Updated:December 8, 2023Completed
Condition(s):Impacted Third Molar Tooth; Healing Surgical WoundsLast Updated:June 18, 2020Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:March 18, 2022Unknown status
Condition(s):Fever; Neutropenia; CancerLast Updated:November 2, 2020Terminated
Condition(s):Helicobacter Pylori InfectionLast Updated:January 26, 2021Completed
Condition(s):Helicobacter InfectionLast Updated:October 4, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.